EFFECTIVE ROLE OF THE PROPOLIS AGAINST HEPATOCELLULAR DAMAGE OF TOXIC DRUGS IN ALBINO RATS
DOI:
https://doi.org/10.60127/qtnkrk22Keywords:
Propolis, Liver Function Test (LFTs), Anti-tuberculosis treatment (ATTs), Hepato-toxicity, antioxidant, ALTAbstract
Objective: The main purpose of this study is to evaluate the hepatoprotective effects of propolis in hepatocyte injury caused by Anti-tuberculosis treatment (ATT) due to isoniazid and rifampicin.
Methodology: Healthy albino rats with an average weight of 200-250g were included in this study. These rats were divided into main four groups, a group was taken as the control group and then the rest were group B, group C, and group D, designated as experimental groups. The control group had 15 rats with measured weight, they were given distilled water. Group B had 15 rats, they were given with standard dose of rifampicin and isoniazid. Group C had 15 rats, they were also given with standard dose of rifampicin and isoniazid. Group D had 15 rats, they were given a standard dose of rifampicin and isoniazid and also the extract of the propolis we given to this group.
Results: Serum ALT level in experimental group B with group C, and group D was also found to be statistically significant with a p-value < 0.001. ALT serum level was observed high in group B. Multiple comparisons between groups revealed that group B with a significant increase in the serum enzyme AST level in comparison to group A, group C, and group D with p-value <0.001.
Conclusion: This study showed that ethanolic extract of propolis prevents isoniazid and rifampicin-induced hepatotoxicity in albino rats.
Keywords: Propolis, Liver Function Test (LFTs), Anti-tuberculosis treatment (ATTs), Hepato-toxicity, antioxidant, ALT, AST
Cite this Article as: Arshad A., Haq I. , Pervaiz S., Haleema S., Ahsan U., Iqbal S., Shamim S., Ahmad K.,; Effective Role of the Propolis against Hepatocellular Damage of Toxic Drugs in Albino Rats.; SIAL J Med. Sci. Sept-2024 V-3 (Issue-09):12-18
Submission completed: April, 2024
Review began: April, 2024
Review ended: May, 2024,
Accepted: June, 2024
Published: September, 2024
Downloads
Published
Issue
Section
License
Authors retain the copyright to their work and grant the Sial Journal of Medical Sciences the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
